Press release
The immune system as the key: Dendritic cell therapy opens up new perspectives in modern oncology
dendritic cell therapy immuno-oncology ( (C) IMMUMEDIC Limited)
Dendritic cells - Nobel Prize, function, scientific basis
Dendritic cells are the 'masters' of the immune system. They present antigens - i.e. characteristics of pathological cells - to the T cells and thus trigger a targeted immune response. Dr. Ralph M. Steinman was awarded the Nobel Prize in Medicine in 2011 for this groundbreaking discovery.
In dendritic cell therapy (DZT), immune cells are taken from the patient, grown into dendritic cells in the laboratory and then loaded with tumor antigens. These cells then 'train' the immune system to recognize and destroy malignant cells.
Current studies show progress in solid tumors
1. breast cancer
Borges F. et al. (2024): 'Trial watch: Anticancer vaccination with dendritic cells'
-> Overview of clinical advances in DC vaccines in solid tumors, including breast cancer.
2. prostate cancer
Hawlina S. et al. (2023): 'Potential of personalized dendritic cell-based vaccine for prostate cancer'
-> Presentation of personalized DC vaccination strategies in metastatic prostate cancer, with a focus on immune activation and long-term survival.
3. pancreatic cancer
McMillan MT. et al. (2025): 'Advances in Vaccine-Based Therapies for Pancreatic Cancer'
-> Latest approaches combine DC vaccination with immune checkpoint modulation for better detection of 'immunologically cold' tumors.
Case study - When the immune system fights again
Mrs. M., 56 years old, was diagnosed with 'local recurrence' after breast cancer surgery. She refused further chemotherapy. After undergoing dendritic cell therapy in combination with immune boosting, her general condition stabilized significantly, inflammation markers decreased and she felt better.
"I have the feeling that my body can fight for itself again," she reports.
How IMMUMEDIC supports patients
IMMUMEDIC is an international platform for personalized immunotherapy and medical logistics. The company accompanies patients on their path to innovative treatment options - from diagnostic testing to cell production in certified European GMP laboratories.
Process at IMMUMEDIC:
1. submission of findings & second medical opinion
2. coordination of blood collection & cell processing
3. production of the individual cell therapy
4. return & medically supervised application
5. aftercare with tumor cell count (CTCs) and progress monitoring
"The immune system is the most important ally against cancer."
These words summarize what research has proven today: Not every cancer cell can be operated on, irradiated or poisoned - but your own immune system can learn to recognize them. More and more doctors, oncologists and alternative practitioners are combining conventional therapies with immunological procedures to bring the body back into balance.
Free therapy assessment
Patients can request a free second opinion via IMMUMEDIC. All they need to do is send in their most recent findings and blood values. Within 48 hours, an individual assessment will be made as to whether dendritic cell therapy or immune boosting therapy with ImmuSeroForte is appropriate. You will receive a free report including study links without any promise of a cure.
Link: www.dendritische-zelltherapie-deutschland.com
Conclusion
Today, cell immunotherapy is considered one of the most exciting approaches in modern cancer research. It combines the biological intelligence of the immune system with modern cell technology - and offers new perspectives beyond traditional chemotherapy, particularly for advanced diseases. The combination of science, experience and individual care makes IMMUMEDIC an important companion in this new era of personalized cancer medicine.
IMMUMEDIC Limited
Bessemerstrasse 51 1.OG
12103
Germany
https://www.dendritische-zelltherapie-deutschland.com/
Andreas Rach
0034654431317
immumedic@gmail.com
IMMUMEDIC - Network for innovative immunotherapies
IMMUMEDIC is not just a provider of advanced cancer therapies, but a Europe-wide network that makes it easier for patients to access modern immunotherapies. At the heart of the network are specialized private clinics, medical practices and specialists in Germany and Europe who jointly offer integrative, individualized therapies. Thanks to this structure, patients benefit from an interdisciplinary approach that combines oncology, immunology and complementary medicine.
IMMUMEDIC - Your network for innovative immunotherapies and holistic health solutions
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The immune system as the key: Dendritic cell therapy opens up new perspectives in modern oncology here
News-ID: 4237517 • Views: …
More Releases from IMMU
Dendritic cell therapy shows success in lung cancer with metastases.
While conventional oncology often reaches its limits in metastatic lung cancer, modern immunotherapy offers new hope: dendritic cell therapy (DZT) uses the body's own immune intelligence to specifically recognize and combat tumour cells.
Functional principle of dendritic cell therapy
Dendritic cells are considered the "generals" of the immune system.
They present the characteristic antigens of tumour cells to the immune system and thereby activate specific killer cells (T cells), which recognize and destroy…
Cancer & Metastases: The role of apoptosis - and how adjuvant therapies can supp …
Many cancer cells manage to switch off natural cell death - known as apoptosis. It is precisely this "safety mechanism" in the healthy body that ensures that defective cells are broken down in an orderly fashion and replaced by new, healthy cells.
In the case of metastases, it is particularly important to reactivate or support this protective function, as this prevents tumor cells from continuing to multiply uncontrollably.
Apoptosis - simply explained
Think…
Combination therapies against the five most dangerous cancers - hope for sustain …
Cancer continues to be one of the biggest health challenges worldwide. In particular, tumor types such as lung cancer, breast cancer, pancreatic cancer, colorectal cancer and aggressive glioblastoma are considered the most dangerous and most common forms of cancer. Despite advances in diagnostics and therapy, treatment remains complex, especially when metastases occur.
However, medical innovations show that optimal combination therapies open up new perspectives: Through the targeted interaction of surgical interventions,…
Why waiting for a diagnosis of "metastases is dangerous?
Why waiting is dangerous - New hope for metastases through immunotherapy with dendritic cells and "ImmuSeroForte"
The appearance of metastases in cancer is a shock for many patients and their relatives. In breast cancer in particular, but also in other types of tumor, metastases are often the turning point of the disease - they can become life-threatening.
But an important message is: waiting is not an option. The faster action is taken,…
More Releases for IMMUMEDIC
Dendritic cell therapy shows success in lung cancer with metastases.
While conventional oncology often reaches its limits in metastatic lung cancer, modern immunotherapy offers new hope: dendritic cell therapy (DZT) uses the body's own immune intelligence to specifically recognize and combat tumour cells.
Functional principle of dendritic cell therapy
Dendritic cells are considered the "generals" of the immune system.
They present the characteristic antigens of tumour cells to the immune system and thereby activate specific killer cells (T cells), which recognize and destroy…
Cancer & Metastases: The role of apoptosis - and how adjuvant therapies can supp …
Many cancer cells manage to switch off natural cell death - known as apoptosis. It is precisely this "safety mechanism" in the healthy body that ensures that defective cells are broken down in an orderly fashion and replaced by new, healthy cells.
In the case of metastases, it is particularly important to reactivate or support this protective function, as this prevents tumor cells from continuing to multiply uncontrollably.
Apoptosis - simply explained
Think…
Combination therapies against the five most dangerous cancers - hope for sustain …
Cancer continues to be one of the biggest health challenges worldwide. In particular, tumor types such as lung cancer, breast cancer, pancreatic cancer, colorectal cancer and aggressive glioblastoma are considered the most dangerous and most common forms of cancer. Despite advances in diagnostics and therapy, treatment remains complex, especially when metastases occur.
However, medical innovations show that optimal combination therapies open up new perspectives: Through the targeted interaction of surgical interventions,…
Why waiting for a diagnosis of "metastases is dangerous?
Why waiting is dangerous - New hope for metastases through immunotherapy with dendritic cells and "ImmuSeroForte"
The appearance of metastases in cancer is a shock for many patients and their relatives. In breast cancer in particular, but also in other types of tumor, metastases are often the turning point of the disease - they can become life-threatening.
But an important message is: waiting is not an option. The faster action is taken,…
Cancer in the workplace: How companies can support employees
Supporting employees during their illness - and why this is also economically worthwhile
A cancer diagnosis changes life abruptly - not only for those affected, but also for those around them. The workplace in particular plays a central role during this time. More and more companies are realizing that actively supporting sick employees is not only a human gesture, but can also make good business sense.
Health is an economic factor
Around half…
Treatment of metastases
As an affected patient, you are aware of one thing: when you are diagnosed with cancer, everything changes, from your quality of life to your everyday life. Surgical removal of the primary tumor is often attempted. If this does not work, radiotherapy or chemotherapy is tried, and hormone therapy is also used for certain types of cancer. Most doctors who do not work scientifically are skeptical of the new forms…
